| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Cabergoline | FAERS: 5 | OFFSIDES US FAERS | |
| 2 | ropinirole | FAERS: 4 | OFFSIDES US FAERS | |
| 3 | Aspirin-oxycodone hydrochloride-oxycodone terephthalate combination | FAERS: 1 | US FAERS | |
| 4 | Sitagliptin Phosphate | FAERS: 1 | US FAERS | |
| 5 | Valsartan | FAERS: 1 | US FAERS | |
| 6 | deflazacort | FAERS: 1 | US FAERS | |
| 7 | rofecoxib | FAERS: 1 | US FAERS | |
| 8 | Lenalidomide | OFFSIDES | ||
| 9 | Letrozole | OFFSIDES | ||
| 10 | Levodopa | OFFSIDES | ||
| 11 | Pamidronate | OFFSIDES | ||
| 12 | Pergolide | OFFSIDES | ||
| 13 | Telmisartan | Canada Vigilance: 1 | Canada Vigilance | |
| 14 | Triamterene | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.